NOT KNOWN FACTUAL STATEMENTS ABOUT AZELAPRAG SMALL MOLECULE

The choice follows observations of liver transaminitis without having clinically sizeable signs, and devoid of clear dose dependence, in certain individuals while in the azelaprag arms with the STRIDES Section two clinical trial for weight problems (connection).On top of that, the combination restored body composition and muscle function to that of